INNOVATIONS

Description

HSK GeneTech Limited was founded by a group of research scientists led by Prof. Hoi Shan Kwan of School of Life Sciences, the Chinese University of Hong Kong (CUHK). The Company's team of scientists, mostly PhDs, possess one of the territories' best expertise in the field of genomics and high throughput sequencing. The team has over 40 years of research and development experience in microbiology and DNA technology, and over 10 years of experience in providing Next-Generation Sequencing (NGS). The Company will expand the service to the general public as paid service. The Company will disrupt the nutrition market by introducing the state-of-the-art gut microbiome analysis for health promotion. The upcoming service and product includes: Using microbiome sequencing technology to develop service for managing health conditions, including i) provide service schemes for adult weight management and children health; ii) Construct Asian gut microbiome-diet database for industry big data analysis and application; and iii) Develop prebiotics and probiotics food products. The Company's aim is to IPO in four years time. With the aid of the TSSSU, the company will have a first step to become a groundbreaking biotech-health management company in Hong Kong.